These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31639843)

  • 21. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kuntzer T
    Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
    Peltier AC; Donofrio PD
    Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CIDP Refractory to Three Types of Mainstay Treatments: Differential Diagnosis and Treatment Strategies].
    Iijima M
    Brain Nerve; 2022 May; 74(5):517-524. PubMed ID: 35589641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic inflammatory demyelinating polyneuropathy.
    Kleyman I; Brannagan TH
    Curr Neurol Neurosci Rep; 2015 Jul; 15(7):47. PubMed ID: 26008811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
    Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
    J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
    J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
    Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
    Silwal A; Pitt M; Phadke R; Mankad K; Davison JE; Rossor A; DeVile C; Reilly MM; Manzur AY; Muntoni F; Munot P
    Neuromuscul Disord; 2018 Sep; 28(9):757-765. PubMed ID: 30072201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
    Kim W; Shim YK; Choi SA; Kim SY; Kim H; Lim BC; Hwang H; Choi J; Kim KJ; Chae JH
    Neuromuscul Disord; 2019 Sep; 29(9):684-692. PubMed ID: 31473049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Pashenkov M; Jin JP; Link H
    J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
    Adrichem ME; Eftimov F; van Schaik IN
    J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Teramoto H; Morita A; Hara M; Ninomiya S; Shigihara S; Kusunoki S; Kamei S
    Intern Med; 2015; 54(14):1791-3. PubMed ID: 26179538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the diagnosis, pathogenesis and treatment of CIDP.
    Dalakas MC;
    Nat Rev Neurol; 2011 Aug; 7(9):507-17. PubMed ID: 21844897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2010 Mar; 15(1):1-9. PubMed ID: 20433600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.